madman
Super Moderator
Shalin Shah is the CEO of Marius Pharmaceuticals and a leader in metabolic and men’s health. He spearheaded the FDA approval of the first oral testosterone therapy for men with low testosterone. With a mission to make hormone health more accessible, Shalin advocates for education, innovation, and redefining testosterone therapy as a foundation for longevity and quality of life.
What We Talk About:
- Why testosterone levels are rapidly declining in both men and women.
- The connection between low testosterone, obesity, and chronic metabolic disease.
- How environmental toxins, plastics, and fragrances disrupt hormones.
- The symptoms and early warning signs of testosterone deficiency.
- Why younger men are now showing record-low testosterone levels.
- What to test for: total vs. free testosterone, SHBG, LH, FSH, and estradiol.
- The problem with “normal” lab ranges and how they’ve shifted over time.
- Comparing injections, gels, pellets, and oral testosterone therapy.
- Why oral testosterone is changing the future of hormone replacement.
- The safety differences between delivery methods and how to minimize side effects.
- Myths about testosterone and heart disease, cardiovascular risk, and prostate cancer.
- How testosterone impacts mood, energy, metabolism, and longevity.
- The fertility question: how TRT affects sperm count and new studies addressing it.
- Why testing testosterone should be part of standard preventive care.
- The future of hormone optimization for women and the FDA’s changing approach.
